Ƶ

Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Liberty - Outstanding Awards (Details)

v3.22.4
Stock-Based Compensation - Liberty - Outstanding Awards (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Additional disclosures
Total unrecognized compensation cost related to unvested equity awards $ 31
Weighted average period of recognition related to unvested equity awards (in years) 1 year 4 months 24 days
Options, exercises in period, total intrinsic value $ 84 $ 144 $ 8
Restricted Stock and Restricted Stock Units
Additional disclosures
Equity instruments other than options, vested in period, fair value $ 16 $ 13 $ 45
Liberty SiriusXM Group
Additional disclosures
Common stock reserved for issuance 6,900
Liberty SiriusXM Group | Common Class A and B
Number of options
Outstanding at end of period 0
Liberty SiriusXM Group | Series C
Number of options
Outstanding at beginning of period 7,369
Granted 254
Exercised (760)
Forfeited/Cancelled (1)
Outstanding at end of period 6,862 7,369
Exercisable at end of period 4,883
WAEP
Outstanding at beginning of period $ 38.79
Granted 44.29
Exercised 31.22
Forfeited/Cancelled 31.87
Outstanding at end of period 39.83 $ 38.79
Exercisable at end of period $ 37.89
Additional disclosures
Weighted average remaining life, outstanding 2 years 9 months 18 days
Weighted average remaining life, exercisable 2 years 2 months 12 days
Aggregate intrinsic value, outstanding $ 14
Aggregate intrinsic value, exercisable $ 14
Liberty SiriusXM Group | Restricted Stock and Restricted Stock Units
Additional disclosures
Equity instruments other than options, nonvested, number 73
Restricted stock weighted average grant-date fair value $ 41.28
Formula One Group
Additional disclosures
Common stock reserved for issuance 7,100
Formula One Group | Common Class A and B
Number of options
Outstanding at end of period 0
Formula One Group | Series C
Number of options
Outstanding at beginning of period 9,114
Granted 301
Exercised (2,329)
Outstanding at end of period 7,086 9,114
Exercisable at end of period 5,625
WAEP
Outstanding at beginning of period $ 34.38
Granted 57.92
Exercised 31.96
Outstanding at end of period 36.18 $ 34.38
Exercisable at end of period $ 34.19
Additional disclosures
Weighted average remaining life, outstanding 3 years 9 months 18 days
Weighted average remaining life, exercisable 3 years 6 months
Aggregate intrinsic value, outstanding $ 167
Aggregate intrinsic value, exercisable $ 144
Formula One Group | Restricted Stock and Restricted Stock Units
Additional disclosures
Equity instruments other than options, nonvested, number 74
Restricted stock weighted average grant-date fair value $ 55.34
Braves Group
Additional disclosures
Common stock reserved for issuance 3,100
Braves Group | Common Class A and B
Number of options
Outstanding at end of period 0
Braves Group | Series C
Number of options
Outstanding at beginning of period 3,125
Granted 105
Exercised (122)
Outstanding at end of period 3,108 3,125
Exercisable at end of period 1,493
WAEP
Outstanding at beginning of period $ 25.86
Granted 26.20
Exercised 18.12
Outstanding at end of period 26.17 $ 25.86
Exercisable at end of period $ 24.92
Additional disclosures
Weighted average remaining life, outstanding 4 years 4 months 24 days
Weighted average remaining life, exercisable 3 years 10 months 24 days
Aggregate intrinsic value, outstanding $ 19
Aggregate intrinsic value, exercisable $ 11
Braves Group | Restricted Stock and Restricted Stock Units
Additional disclosures
Equity instruments other than options, nonvested, number 178
Restricted stock weighted average grant-date fair value $ 31.55